reglab/statecodes huggingface dataset:
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › UNSEALED RADIOACTIVE MATERIAL - WRITTEN DIRECTIVE NOT REQUIRED › Section 246-240-160 - Permissible molybdenum-99, strontium-82, and strontium-85 concentrations

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee may
				  not administer to humans a radiopharmaceutical that contains more than:
(a) 0.15 kilobecquerel of molybdenum-99 per
				  megabecquerel of technetium-99m (0.15 microcurie of molybdenum-99 per
				  millicurie of technetium-99m); or
(b) 0.02 kilobecquerel of strontium-82 per
				  megabecquerel of rubidium-82 chloride injection, (0.02 microcurie of
				  strontium-82 per millicurie of rubidium-82 chloride); or
(c) 0.2 kilobecquerel of strontium-85 per
				  megabecquerel of rubidium-82 chloride injection (0.2 microcurie of strontium-85
				  per millicurie of rubidium-82).
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › UNSEALED RADIOACTIVE MATERIAL - WRITTEN DIRECTIVE NOT REQUIRED › Section 246-240-163 - Training for imaging and localization studies

Current through Register Vol. 24-14, July 15, 2024
Except as provided in WAC
					 246-240-078,
					 the licensee shall require an authorized user of unsealed radioactive material
					 for the uses authorized under WAC
					 246-240-157
					 to be a physician who:
(1) Is
				  certified by a medical specialty board whose certification process has been
				  recognized by the department, NRC, or an agreement state. The names of board
				  certifications that have been recognized by the department, NRC, or an
				  agreement state are posted on the NRC's medical uses licensee toolkit web page.
				  To have its certification process recognized, a specialty board shall require
				  all candidates for certification to:
(a)
				  Complete 700 hours of training and experience in basic radionuclide handling
				  techniques and radiation safety applicable to the medical use of unsealed
				  radioactive material for imaging and localization studies as described in
				  subsection (3)(a)(i) through (ii)(G) of this section; and
(b) Pass an examination, administered by
				  diplomates of the specialty board, which assesses knowledge and competence in
				  radiation safety, radionuclide handling, and quality control;
				  or
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › UNSEALED RADIOACTIVE MATERIAL - WRITTEN DIRECTIVE REQUIRED › Section 246-240-201 - Use of unsealed radioactive material for which a written directive is required

Current through Register Vol. 24-14, July 15, 2024
A licensee may use any unsealed radioactive material
					 identified in WAC
					 246-240-210(2)(a)(ii)(G) prepared for medical use and for which a written directive is required that
					 is:
(1) Obtained from a manufacturer,
				  producer, or preparer licensed under WAC
				  246-235-100(1) or equivalent agreement state or NRC requirements; or
(2) Prepared by an authorized nuclear
				  pharmacist, a physician who is an authorized user and who meets the
				  requirements specified in WAC
				  246-240-163
				  or
				  246-240-210,
				  or an individual under the supervision of either as specified in WAC
				  246-240-057;
				  or
(3) Obtained from and prepared
				  by an agreement state or NRC licensee for use in research in accordance with an
				  investigational new drug protocol accepted by FDA; or
(4) Prepared by the licensee for use in
				  research in accordance with an investigational new drug protocol accepted by
				  FDA.
Statutory Authority:
						RCW
						   70.98.050 and
						70.98.080. 09-06-003, §
						246-240-201, filed 2/18/09, effective 3/21/09. Statutory Authority:
						RCW
						   70.98.050. 06-05-019, § 246-240-201,
						filed 2/6/06, effective 3/9/06.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › UNSEALED RADIOACTIVE MATERIAL - WRITTEN DIRECTIVE REQUIRED › Section 246-240-204 - Safety instruction

Current through Register Vol. 24-14, July 15, 2024
In addition to the requirements of WAC
					 246-222-030:
(1) A licensee shall provide radiation safety
				  instruction, initially and at least annually, to personnel caring for patients
				  or human research subjects who cannot be released under WAC
				  246-240-122. To satisfy this
				  requirement, the instruction must be commensurate with the duties of the
				  personnel and include:
(a) Patient or human
				  research subject control;
(b)
				  Visitor control, including:
(i) Routine
				  visitation to hospitalized individuals in accordance with WAC
				  246-221-060(1)(a);
				  and
(ii) Visitation authorized in
				  accordance with WAC
				  246-221-060(2);
(c) Contamination
				  control;
(d) Waste control;
				  and
(e) Notification of the
				  radiation safety officer, or their designee, and the authorized user if the
				  patient or the human research subject has a medical emergency or
				  dies.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › UNSEALED RADIOACTIVE MATERIAL - WRITTEN DIRECTIVE REQUIRED › Section 246-240-207 - Safety precautions

Current through Register Vol. 24-14, July 15, 2024
(1)
				  For each patient or human research subject who cannot be released under WAC
				  246-240-122, a licensee shall:
(a) Quarter the patient or the human research
				  subject either in:
(i) A private room with a
				  private sanitary facility; or
(ii)
				  A room, with a private sanitary facility, with another individual who also has
				  received therapy with unsealed radioactive material and who also cannot be
				  released under WAC
				  246-240-122;
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › UNSEALED RADIOACTIVE MATERIAL - WRITTEN DIRECTIVE REQUIRED › Section 246-240-210 - Training for use of unsealed radioactive material for which a written directive is required

Current through Register Vol. 24-14, July 15, 2024
Except as provided in WAC 246-240-078, the licensee shall
					 require an authorized user of unsealed radioactive material for the uses
					 authorized under WAC 246-240-201 to be a physician who:
(1) Is certified by a medical specialty board
				  whose certification process has been recognized by the department, NRC, or an
				  agreement state and who meets the requirements in subsection (2)(a)(ii)(G) of
				  this section. The names of board certifications that have been recognized by
				  the department, NRC, or an agreement state are posted on the NRC's medical uses
				  licensee toolkit web page. To have its certification process recognized, a
				  specialty board shall require all candidates for certification to:
(a) Successfully complete a residency
				  training in a radiation therapy or nuclear medicine training program or a
				  program in a related medical specialty that includes 700 hours of training and
				  experience as described in subsection (2)(a)(i) through (ii)(E) of this
				  section. Eligible training programs must be approved by the Residency Review
				  Committee of the Accreditation Council for Graduate Medical Education or Royal
				  College of Physicians and Surgeons of Canada or the Council on Postdoctoral
				  Training of the American Osteopathic Association; and
(b) Pass an examination, administered by
				  diplomates of the specialty board, which tests knowledge and competence in
				  radiation safety, radionuclide handling, quality assurance, and clinical use of
				  unsealed radioactive material for which a written directive is required;
				  or
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › UNSEALED RADIOACTIVE MATERIAL - WRITTEN DIRECTIVE REQUIRED › Section 246-240-213 - Training for the oral administration of sodium iodide I-131 requiring a written directive in quantities less than or equal to 122 gigabecquerels (33 millicuries)

Current through Register Vol. 24-14, July 15, 2024
Except as provided in WAC
					 246-240-078,
					 the licensee shall require an authorized user for the oral administration of
					 sodium iodide I-131 requiring a written directive in quantities less than or
					 equal to 1.22 gigabecquerels (33 millicuries), to be a physician who:
(1) Is certified by a medical specialty board
				  whose certification process includes all of the requirements in subsection
				  (3)(a) and (b) of this section and whose certification has been recognized by
				  the department, NRC, or an agreement state. The names of board certifications
				  that have been recognized by the department, NRC, or an agreement state are
				  posted on the NRC's medical uses licensee toolkit web page; or
(2) Is an authorized user under WAC
				  246-240-210
				  for uses listed in WAC
				  246-240-210(2)
				  (a)(ii)(G)(I) or (II),
				  246-240-216,
				  or equivalent agreement state or NRC requirements; or
(3)
(a) Has
				  successfully completed 80 hours of classroom and laboratory training,
				  applicable to the medical use of sodium iodide I-131 for procedures requiring a
				  written directive. The training must include:
(i) Radiation physics and
				  instrumentation;
(ii) Radiation
				  protection;
(iii) Mathematics
				  pertaining to the use and measurement of radioactivity;
(iv) Chemistry of radioactive material for
				  medical use; and
(v) Radiation
				  biology; and
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › UNSEALED RADIOACTIVE MATERIAL - WRITTEN DIRECTIVE REQUIRED › Section 246-240-216 - Training for the oral administration of sodium iodide I-131 requiring a written directive in quantities greater than 122 gigabecquerels (33 millicuries)

Current through Register Vol. 24-14, July 15, 2024
Except as provided in WAC
					 246-240-078,
					 the licensee shall require an authorized user for the oral administration of
					 sodium iodide I-131 requiring a written directive in quantities greater than
					 1.22 gigabecquerels (33 millicuries), to be a physician who:
(1) Is certified by a medical specialty board
				  whose certification process includes all of the requirements in subsection
				  (3)(a) and (b) of this section and whose certification has been recognized by
				  the department, NRC, or an agreement state. The names of board certifications
				  that have been recognized by the department, NRC, or an agreement state are
				  posted on the NRC's medical uses licensee toolkit web page; or
(2) Is an authorized user under WAC
				  246-240-210
				  for uses listed in WAC
				  246-240-210(2)
				  (a)(ii)(G)(II), or equivalent agreement state
				  or NRC requirements; or
(3)
(a) Has successfully completed 80 hours of
				  classroom and laboratory training, applicable to the medical use of sodium
				  iodide I-131 for procedures requiring a written directive. The training must
				  include:
(i) Radiation physics and
				  instrumentation;
(ii) Radiation
				  protection;
(iii) Mathematics
				  pertaining to the use and measurement of radioactivity;
(iv) Chemistry of radioactive material for
				  medical use; and
(v) Radiation
				  biology; and
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › UNSEALED RADIOACTIVE MATERIAL - WRITTEN DIRECTIVE REQUIRED › Section 246-240-219 - Training for the parenteral administration of unsealed radioactive material requiring a written directive

Current through Register Vol. 24-14, July 15, 2024
(1)
				  Except as provided in WAC
				  246-240-078,
				  the licensee shall require an authorized user for the parenteral administration
				  requiring a written directive, to be a physician who:
(a) Is an authorized user under WAC
				  246-240-210
				  for uses listed in WAC
				  246-240-210(2)
				  (a)(ii)(G)(III), or equivalent agreement
				  state or NRC requirements; or
(b)
				  Is an authorized user under WAC
				  246-240-278
				  or
				  246-240-399,
				  or equivalent agreement state or NRC requirements and who meets the
				  requirements in subsection (2) of this section; or
(c) Is certified by a medical specialty board
				  whose certification process has been recognized by the NRC or an agreement
				  state under WAC
				  246-240-278
				  or
				  246-240-399,
				  and who meets the requirements in subsection (2) of this
				  section.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › MANUAL BRACHYTHERAPY › Section 246-240-251 - Use of sources for manual brachytherapy

Current through Register Vol. 24-14, July 15, 2024
A licensee shall use only brachytherapy sources for
					 therapeutic medical uses:
(1) As
				  approved in the sealed source and device registry for manual brachytherapy
				  medical use. The manual brachytherapy sources may be used for manual
				  brachytherapy uses that are not explicitly listed in the sealed source and
				  device registry, but must be used in accordance with the radiation safety
				  conditions and limitations described in the sealed source and device registry;
				  or
(2) In research to deliver
				  therapeutic doses for medical use in accordance with an active investigational
				  device exemption (IDE) application accepted by the FDA provided the
				  requirements of WAC
				  246-240-066(1) are met.
Statutory Authority:
						RCW
						   70.98.050. 06-05-019, § 246-240-251,
						filed 2/6/06, effective 3/9/06.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › MANUAL BRACHYTHERAPY › Section 246-240-254 - Surveys after source implant and removal

Current through Register Vol. 24-14, July 15, 2024
(1) Immediately after implanting sources in a
				  patient or a human research subject, the licensee shall make a survey to locate
				  and account for all sources that have not been implanted.
(2) Immediately after removing the last
				  temporary implant source from a patient or a human research subject, the
				  licensee shall make a survey of the patient or the human research subject with
				  a radiation detection survey instrument to confirm that all sources have been
				  removed.
(3) A licensee shall
				  retain a record of the surveys required by subsections (1) and (2) of this
				  section in accordance with WAC
				  246-240-593.
Statutory Authority:
						RCW
						70.98.050. 06-05-019, § 246-240-254,
						filed 2/6/06, effective 3/9/06.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › MANUAL BRACHYTHERAPY › Section 246-240-260 - Brachytherapy source accountability

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee shall maintain accountability
				  at all times for all brachytherapy sources in storage, transport, or
				  use.
(2) As soon as possible after
				  removing sources from a patient or a human research subject, a licensee shall
				  return brachytherapy sources to a secure storage area.
(3) A licensee shall maintain a record of the
				  brachytherapy source accountability in accordance with WAC
				  246-240-596.
Statutory Authority:
						RCW
						70.98.050. 06-05-019, § 246-240-260,
						filed 2/6/06, effective 3/9/06.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › MANUAL BRACHYTHERAPY › Section 246-240-263 - Safety instruction

Current through Register Vol. 24-14, July 15, 2024
In addition to the requirements of WAC
					 246-222-030:
(1) The licensee shall provide radiation
				  safety instruction, initially and at least annually, to personnel caring for
				  patients or human research subjects who are receiving brachytherapy and cannot
				  be released under WAC
				  246-240-122. To satisfy this
				  requirement, the instruction must be commensurate with the duties of the
				  personnel and include the:
(a) Size and
				  appearance of the brachytherapy sources;
(b) Safe handling and shielding
				  instructions;
(c) Patient or human
				  research subject control;
(d)
				  Visitor control, including both:
(i) Routine
				  visitation of hospitalized individuals in accordance with WAC
				  246-221-060(1)(a);
				  and
(ii) Visitation authorized in
				  accordance with WAC
				  246-221-060(2);
				  and
(e) Notification of
				  the radiation safety officer, or their designee, and an authorized user if the
				  patient or the human research subject has a medical emergency or
				  dies.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › MANUAL BRACHYTHERAPY › Section 246-240-266 - Safety precautions

Current through Register Vol. 24-14, July 15, 2024
(1)
				  For each patient or human research subject who is receiving brachytherapy and
				  cannot be released under WAC
				  246-240-122, a licensee shall:
(a) Not quarter the patient or the human
				  research subject in the same room as an individual who is not receiving
				  brachytherapy;
(b) Visibly post the
				  patient's or human research subject's room with a "Caution -- Radioactive
				  Materials" sign; and
(c) Note on
				  the door or in the patient's or human research subject's chart where and how
				  long visitors may stay in the patient's or human research subject's
				  room.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › MANUAL BRACHYTHERAPY › Section 246-240-269 - Calibration measurements of brachytherapy sources

Current through Register Vol. 24-14, July 15, 2024
(1) Before the first medical use of a
				  brachytherapy source on or after March 9, 2006, a licensee shall have:
(a) Determined the source output or activity
				  using a dosimetry system that meets the requirements of WAC
				  246-240-366(1);
(b) Determined source positioning accuracy
				  within applicators; and
(c) Used
				  published protocols currently accepted by nationally recognized bodies to meet
				  the requirements of (a) and (b) of this subsection.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › MANUAL BRACHYTHERAPY › Section 246-240-272 - Strontium-90 sources for ophthalmic treatments

Current through Register Vol. 24-14, July 15, 2024
(1) Licensees who use strontium-90 for
				  ophthalmic treatments must ensure that certain activities as specified in
				  subsection (2) of this section are performed by either:
(a) An authorized medical physicist;
				  or
(b) An individual who:
(i) Is identified as an ophthalmic physicist
				  on a specific medical use license issued by a department, NRC, or an agreement
				  state; permit issued by a department, NRC, or an agreement state broad scope
				  medical use licensee; medical use permit issued by an NRC master material
				  licensee; or permit issued by an NRC master material licensee broad scope
				  medical use permittee; and
(ii)
				  Holds a master's or doctor's degree in physics, medical physics, other physical
				  sciences, engineering, or applied mathematics from an accredited college or
				  university; and
(iii) Has
				  successfully completed one year of full-time training in medical physics and an
				  additional year of full-time work experience under the supervision of a medical
				  physicist; and
(iv) Has documented
				  training in:
(A) The creation, modification,
				  and completion of written directives;
(B) Procedures for administrations requiring
				  a written directive; and
(C)
				  Performing the calibration measurements of brachytherapy sources as detailed in
				  WAC
				  246-240-269.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › MANUAL BRACHYTHERAPY › Section 246-240-275 - Therapy-related computer systems

Current through Register Vol. 24-14, July 15, 2024
The licensee shall perform acceptance testing on the
					 treatment planning system of therapy-related computer systems in accordance
					 with published protocols accepted by nationally recognized bodies. At a
					 minimum, the acceptance testing must include, as applicable, verification
					 of:
(1) The source-specific input
				  parameters required by the dose calculation algorithm;
(2) The accuracy of dose, dwell time, and
				  treatment time calculations at representative points;
(3) The accuracy of isodose plots and graphic
				  displays; and
(4) The accuracy of
				  the software used to determine sealed source positions from radiographic
				  images.
Statutory Authority:
						RCW
						70.98.050. 06-05-019, § 246-240-275,
						filed 2/6/06, effective 3/9/06.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › MANUAL BRACHYTHERAPY › Section 246-240-278 - Training for use of manual brachytherapy sources

Current through Register Vol. 24-14, July 15, 2024
Except as provided in WAC 246-240-078, the licensee shall
					 require an authorized user of a manual brachytherapy source for the uses
					 authorized under WAC 246-240-251 to be a physician who:
(1) Is certified by a medical specialty board
				  whose certification process has been recognized by the department, NRC, or an
				  agreement state. The names of board certifications that have been recognized by
				  the department, NRC, or an agreement state are posted on the NRC's medical uses
				  licensee toolkit web page. To have its certification process recognized, a
				  specialty board shall require all candidates for certification to:
(a) Successfully complete a minimum of three
				  years of residency training in a radiation oncology program approved by the
				  Residency Review Committee of the Accreditation Council for Graduate Medical
				  Education or Royal College of Physicians and Surgeons of Canada or the Council
				  on Postdoctoral Training of the American Osteopathic Association; and
(b) Pass an examination, administered by
				  diplomates of the specialty board, which tests knowledge and competence in
				  radiation safety, radionuclide handling, treatment planning, quality assurance,
				  and clinical use of manual brachytherapy; or
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › MANUAL BRACHYTHERAPY › Section 246-240-281 - Training for ophthalmic use of strontium-90

Current through Register Vol. 24-14, July 15, 2024
Except as provided in WAC
					 246-240-078,
					 the licensee shall require the authorized user of strontium-90 for ophthalmic
					 radiotherapy to be a physician who:
(1) Is an authorized user under WAC
				  246-240-278
				  or equivalent agreement state or NRC requirements; or
(2)
(a) Has
				  completed 24 hours of classroom and laboratory training applicable to the
				  medical use of strontium-90 for ophthalmic radiotherapy. The training must
				  include:
(i) Radiation physics and
				  instrumentation;
(ii) Radiation
				  protection;
(iii) Mathematics
				  pertaining to the use and measurement of radioactivity; and
(iv) Radiation biology; and
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › SEALED SOURCES FOR DIAGNOSIS › Section 246-240-301 - Use of sealed sources and medical devices for diagnosis

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee
				  shall use only sealed sources that are not in medical devices for diagnostic
				  medical uses if the sealed sources are approved in the sealed source and device
				  registry for diagnostic medicine. The sealed sources may be used for diagnostic
				  medical uses that are not explicitly listed in the sealed source and device
				  registry but must be used in accordance with the radiation safety conditions
				  and limitations described in the sealed source and device registry.
(2) A licensee must only use medical devices
				  containing sealed sources for diagnostic medical uses if both the sealed
				  sources and medical devices are approved in the sealed source and device
				  registry for diagnostic medical uses. The diagnostic medical devices may be
				  used for diagnostic medical uses that are not explicitly listed in the sealed
				  source and device registry but must be used in accordance with the radiation
				  safety conditions and limitations described in the sealed source and device
				  registry.
(3) Sealed sources and
				  devices for diagnostic medical uses may be used in research in accordance with
				  an active IDE application accepted by the FDA provided the requirements of WAC
				  246-240-066(1) are met.
Statutory Authority:
						RCW
						   70.98.050. 06-05-019, § 246-240-301,
						filed 2/6/06, effective 3/9/06.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › SEALED SOURCES FOR DIAGNOSIS › Section 246-240-304 - Training for use of sealed sources and medical devices for diagnosis

Current through Register Vol. 24-14, July 15, 2024
Except as provided in WAC
					 246-240-078,
					 the licensee shall require the authorized user of a diagnostic sealed source a
					 device authorized under WAC
					 246-240-301
					 to be a physician, dentist, or podiatrist who:
(1) Is certified by a specialty board whose
				  certification process includes all of the requirements in subsections (3) and
				  (4) of this section and whose certification has been recognized by the
				  department, NRC, or an agreement state. The names of board certifications that
				  have been recognized by the department, NRC, or an agreement state are posted
				  on the NRC's medical uses licensee toolkit web page; or
(2) Is an authorized user for uses listed in
				  WAC
				  246-240-157
				  or equivalent NRC or agreement state requirements; or
(3) Has completed eight hours of classroom
				  and laboratory training in basic radionuclide handling techniques specifically
				  applicable to the use of the device. The training must include:
(a) Radiation physics and
				  instrumentation;
(b) Radiation
				  protection;
(c) Mathematics
				  pertaining to the use and measurement of radioactivity;
(d) Radiation biology; and
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-351 - Use of a sealed source in a remote afterloader unit, teletherapy unit, or gamma stereotactic radiosurgery unit

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee shall use sealed sources:
(a) Approved and as provided for in the
				  sealed source and device registry in photon emitting remote afterloader units,
				  teletherapy units, or gamma stereotactic radiosurgery units to deliver
				  therapeutic doses for medical uses; or
(b) In research involving photon-emitting
				  remote afterloader units, teletherapy units, or gamma stereotactic radiosurgery
				  units in accordance with an active IDE application accepted by the FDA provided
				  the requirements of WAC
				  246-240-066(1) are met.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-354 - Surveys of patients and human research subjects treated with a remote afterloader unit

Current through Register Vol. 24-14, July 15, 2024
(1) Before
				  releasing a patient or a human research subject from licensee control, a
				  licensee shall survey the patient or the human research subject and the remote
				  afterloader unit with a portable radiation detection survey instrument to
				  confirm that the sources has been removed from the patient or human research
				  subject and returned to the safe shielded position.
(2) A licensee shall retain a record of these
				  surveys in accordance with WAC
				  246-240-593.
Statutory Authority:
						RCW
						   70.98.050. 06-05-019, § 246-240-354,
						filed 2/6/06, effective 3/9/06.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-357 - Installation, maintenance, adjustment, and repair

Current through Register Vol. 24-14, July 15, 2024
(1) Only a person specifically licensed by
				  the department, NRC, or an agreement state shall install, maintain, adjust, or
				  repair a remote afterloader unit, teletherapy unit, or gamma stereotactic
				  radio-surgery unit that involves work on the sources shielding, the sources
				  driving unit, or other electronic or mechanical component that could expose the
				  sources, reduce the shielding around the sources, or compromise the radiation
				  safety of the unit or the sources.
(2) Except for low dose-rate remote
				  afterloader units, only a person specifically licensed by the department, NRC,
				  or an agreement state shall install, replace, relocate, or remove a sealed
				  source or source contained in other remote afterloader units, teletherapy
				  units, or gamma stereotactic radiosurgery units.
(3) For a low dose-rate remote afterloader
				  unit, only a person specifically licensed by the department, NRC, or an
				  agreement state or an authorized medical physicist shall install, replace,
				  relocate, or remove a sealed sources contained in the unit.
(4) A licensee shall retain a record of the
				  installation, maintenance, adjustment, and repair of remote afterloader units,
				  teletherapy units, and gamma stereotactic radiosurgery units in accordance with
				  WAC
				  246-240-605.
Statutory Authority:
						RCW
						   70.98.050. 06-05-019, § 246-240-357,
						filed 2/6/06, effective 3/9/06.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-360 - Safety procedures and instructions for remote afterloader units, teletherapy units, and gamma stereotactic radiosurgery units

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee shall:
(a) Secure the unit, the console, the console
				  keys, and the treatment room when not in use or unattended;
(b) Permit only individuals approved by the
				  authorized user, radiation safety officer, or authorized medical physicist to
				  be present in the treatment room during treatment with the sources;
(c) Prevent dual operation of more than one
				  radiation producing device in a treatment room if applicable; and
(d) Develop, implement, and maintain written
				  procedures for responding to an abnormal situation when the operator is unable
				  to place the sources in the shielded position, or remove the patient or human
				  research subject from the radiation field with controls from outside the
				  treatment room. These procedures must include:
(i) Instructions for responding to equipment
				  failures and the names of the individuals responsible for implementing
				  corrective actions;
(ii) The
				  process for restricting access to and posting of the treatment area to minimize
				  the risk of inadvertent exposure; and
(iii) The names and telephone numbers of the
				  authorized users, the authorized medical physicist, and the radiation safety
				  officer to be contacted if the unit or console operates abnormally.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-363 - Safety precautions for remote afterloader units, teletherapy units, and gamma stereotactic radiosurgery units

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee shall control access to the
				  treatment room by a door at each entrance.
(2) A licensee shall equip each entrance to
				  the treatment room with an electrical interlock system that will:
(a) Prevent the operator from initiating the
				  treatment cycle unless each treatment room entrance door is closed;
(b) Cause the sources to be shielded when an
				  entrance door is opened; and
(c)
				  Prevent the sources from being exposed following an interlock interruption
				  until all treatment room entrance doors are closed and the sources on-off
				  control is reset at the console.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-366 - Dosimetry equipment

Current through Register Vol. 24-14, July 15, 2024
(1)
				  Except for low dose-rate remote afterloader sources where the source output or
				  activity is determined by the manufacturer, a licensee shall have a calibrated
				  dosimetry system available for use. To satisfy this requirement, one of the
				  following two conditions must be met:
(a) The
				  system must have been calibrated using a system or source traceable to the
				  National Institute of Science and Technology (NIST) and published protocols
				  accepted by nationally recognized bodies; or by a calibration laboratory
				  accredited by the American Association of Physicists in Medicine (AAPM). The
				  calibration must have been performed within the previous two years and after
				  any servicing that may have affected system calibration; or
(b) The system must have been calibrated
				  within the previous four years. Eighteen to 30 months after that calibration,
				  the system must have been intercompared with another dosimetry system that was
				  calibrated within the past 24 months by NIST or by a calibration laboratory
				  accredited by the AAPM. The results of the intercomparison must indicate that
				  the calibration factor of the licensee's system had not changed by more than
				  two percent. The licensee may not use the intercomparison result to change the
				  calibration factor. When intercomparing dosimetry systems to be used for
				  calibrating sealed sources for therapeutic units, the licensee shall use a
				  comparable unit with beam attenuators or collimators, as applicable, and
				  sources of the same radionuclide as the source used at the licensee's
				  facility.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-369 - Full calibration measurements on teletherapy units

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee authorized to use a
				  teletherapy unit for medical use shall perform full calibration measurements on
				  each teletherapy unit:
(a) Before the first
				  medical use of the unit; and
(b)
				  Before medical use under the following conditions:
(i) Whenever spot-check measurements indicate
				  that the output differs by more than five percent from the output obtained at
				  the last full calibration corrected mathematically for radioactive
				  decay;
(ii) Following replacement
				  of the source or following reinstallation of the teletherapy unit in a new
				  location;
(iii) Following any
				  repair of the teletherapy unit that includes removal of the source or major
				  repair of the components associated with the source exposure assembly;
				  and
(c) At intervals not
				  exceeding one year.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-372 - Full calibration measurements on remote after-loader units

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee
				  authorized to use a remote afterloader unit for medical use shall perform full
				  calibration measurements on each unit:
(a)
				  Before the first medical use of the unit;
(b) Before medical use under the following
				  conditions:
(i) Following replacement of the
				  source or following reinstallation of the unit in a new location outside the
				  facility; and
(ii) Following any
				  repair of the unit that includes removal of the source or major repair of the
				  components associated with the source exposure assembly;
				  and
(c) At intervals not
				  exceeding one calendar quarter for high dose-rate, medium dose-rate, and pulsed
				  dose-rate remote afterloader units with sources whose half-life exceeds 75
				  days; and
(d) At intervals not
				  exceeding one year for low dose-rate remote afterloader
				  units.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-375 - Full calibration measurements on gamma stereotactic radiosurgery units

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee
				  authorized to use a gamma stereotactic radiosurgery unit for medical use shall
				  perform full calibration measurements on each unit:
(a) Before the first medical use of the
				  unit;
(b) Before medical use under
				  the following conditions:
(i) Whenever
				  spot-check measurements indicate that the output differs by more than five
				  percent from the output obtained at the last full calibration corrected
				  mathematically for radioactive decay;
(ii) Following replacement of the sources or
				  following reinstallation of the gamma stereotactic radiosurgery unit in a new
				  location; and
(iii) Following any
				  repair of the gamma stereotactic radiosurgery unit that includes removal of the
				  sources or major repair of the components associated with the source assembly;
				  and
(c) At intervals not
				  exceeding one year, with the exception that relative helmet factors need only
				  be determined before the first medical use of a helmet and following any damage
				  to a helmet.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-378 - Periodic spot-checks for teletherapy units

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee authorized to use teletherapy
				  units for medical use shall perform output spot-checks on each teletherapy unit
				  once in each calendar month that include determination of:
(a) Timer accuracy, and timer linearity over
				  the range of use;
(b) On-off
				  error;
(c) The coincidence of the
				  radiation field and the field indicated by the light beam localizing
				  device;
(d) The accuracy of all
				  distance measuring and localization devices used for medical use;
(e) The output for one typical set of
				  operating conditions measured with the dosimetry system described in WAC
				  246-240-366(2);
				  and
(f) The difference between the
				  measurement made in (e) of this subsection and the anticipated output,
				  expressed as a percentage of the anticipated output such as the value obtained
				  at last full calibration corrected mathematically for physical
				  decay).
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-381 - Periodic spot-checks for remote afterloader units

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee authorized to use a remote
				  afterloader unit for medical use shall perform spot-checks of each remote
				  afterloader facility and on each unit:
(a)
				  Before the first use of a high dose-rate, medium dose-rate, or pulsed dose-rate
				  remote afterloader unit on a given day;
(b) Before each patient treatment with a low
				  dose-rate remote af-terloader unit; and
(c) After each source installation.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-384 - Periodic spot-checks for gamma stereotactic radiosurgery units

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee
				  authorized to use a gamma stereotactic radiosurgery unit for medical use shall
				  perform spot-checks of each gamma stereotactic radiosurgery facility and on
				  each unit:
(a) Monthly;
(b) Before the first use of the unit on a
				  given day; and
(c) After each
				  source installation.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-387 - Additional technical requirements for mobile remote afterloader units

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee
				  providing mobile remote afterloader service shall:
(a) Check survey instruments before medical
				  use at each address of use or on each day of use, whichever is more frequent;
				  and
(b) Account for all sources
				  before departure from a client's address of use.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-390 - Radiation surveys

Current through Register Vol. 24-14, July 15, 2024
(1) In addition
				  to the survey requirement in WAC
				  246-221-110(1),
				  a person licensed under this chapter shall make surveys to ensure that the
				  maximum radiation levels and average radiation levels from the surface of the
				  main source safe with the sources in the shielded position do not exceed the
				  levels stated in the sealed source and device registry.
(2) The licensee shall make the survey
				  required by subsection (1) of this section at installation of a new source and
				  following repairs to the sources shielding, the sources driving unit, or other
				  electronic or mechanical component that could expose the source, reduce the
				  shielding around the sources, or compromise the radiation safety of the unit or
				  the sources.
(3) A licensee shall
				  retain a record of the radiation surveys required by subsection (1) of this
				  section in accordance with WAC
				  246-240-629.
Statutory Authority:
						RCW
						   70.98.050. 06-05-019, § 246-240-390,
						filed 2/6/06, effective 3/9/06.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-393 - Full-inspection servicing for teletherapy and gamma stereotactic radiosurgery units

Current through Register Vol. 24-14, July 15, 2024
(1) A licensee
				  shall have each teletherapy unit and gamma stereotactic radiosurgery unit fully
				  inspected and serviced during each source replacement to assure proper
				  functioning of the source exposure mechanism and other safety components. The
				  interval between each full-inspection servicing shall not exceed five years for
				  each teletherapy unit and shall not exceed seven years for each gamma
				  stereotactic radiosurgery unit.
(2)
				  This inspection and servicing may only be performed by persons specifically
				  licensed to do so by the department, NRC, or an agreement state.
(3) A licensee shall keep a record of the
				  inspection and servicing in accordance with WAC
				  246-240-632.
Statutory Authority:
						RCW
						   70.98.050. 06-05-019, § 246-240-393,
						filed 2/6/06, effective 3/9/06.
Washington Administrative Code › Title 246 - Health, Department of › RADIATION › Chapter 246-240 - Radiation protection Medical use of radioactive material › PHOTON EMITTING REMOTE AFTERLOADER UNITS, TELETHERAPY UNITS, AND GAMMA STEREOTACTIC RADIOSURGERY UNITS › Section 246-240-396 - Therapy-related computer systems

Current through Register Vol. 24-14, July 15, 2024
The licensee shall perform acceptance testing on the
					 treatment planning system of therapy-related computer systems in accordance
					 with published protocols accepted by nationally recognized bodies. At a
					 minimum, the acceptance testing must include, as applicable, verification
					 of:
(1) The source-specific input
				  parameters required by the dose calculation algorithm;
(2) The accuracy of dose, dwell time, and
				  treatment time calculations at representative points;
(3) The accuracy of isodose plots and graphic
				  displays;
(4) The accuracy of the
				  software used to determine sealed source positions from radiographic images;
				  and
(5) The accuracy of electronic
				  transfer of the treatment delivery parameters to the treatment delivery unit
				  from the treatment planning system.
Statutory Authority:
						RCW
						70.98.050. 06-05-019, § 246-240-396,
						filed 2/6/06, effective 3/9/06.